SK

Swanith Kapoor

Active Director Director DIN 11662482
DIN 11662482 First appointment Jun 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Swanith Kapoor

Data last updated:

Swanith Kapoor is a Director at Kwality Pharmaceuticals Limited (since 2026). The company operates in Pharma.

DIN 11662482
Primary Designation Director
Industry Pharma
First Appointment 02 Jun 2026
Oldest Company Age 43 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kwality Pharmaceuticals Limited L24232PB1983PLC005426
Director02 Jun 20261983Active

Directorship timeline

Open interactive timeline →
Kwality Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Swanith Kapoor

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swanith Kapoor

Swanith Kapoor currently holds 1 directorship: Kwality Pharmaceuticals Limited (Director, since 02 Jun 2026).

Swanith Kapoor was first appointed on 02 Jun 2026 as Director at Kwality Pharmaceuticals Limited.

The current boards of Swanith Kapoor's companies include Aditya Arora (Kwality Pharmaceuticals Limited), Aditya Arora (Kwality Pharmaceuticals Limited), Ajay Kumar Arora (Kwality Pharmaceuticals Limited), Anju Arora (Kwality Pharmaceuticals Limited), Bhavesh Mahajan (Kwality Pharmaceuticals Limited), Geeta Arora (Kwality Pharmaceuticals Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available